(Q53284202)

13 May 2018

title

High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide. (English)

1 reference

13 May 2018

author

Jens Danielsson

series ordinal

1

1 reference

13 May 2018

Roberta Pierattelli

series ordinal

2

1 reference

13 May 2018

Lucia Banci

series ordinal

3

object named as

Lucia Banci

1 reference

13 May 2018

4

Astrid Gräslund

1 reference

PubMed ID

17222176

13 May 2018

language of work or name

English

0 references

publication date

1 January 2007

1 reference

13 May 2018

published in

FEBS Journal

1 reference

13 May 2018

volume

274

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

46-59

1 reference

13 May 2018

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Metals and amyloid-beta in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

In vivo reduction of amyloid-beta by a mutant copper transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

15N relaxation study of the amyloid beta-peptide: structural propensities and persistence length

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

A specific amyloid-beta protein assembly in the brain impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Copper, iron and zinc in Alzheimer's disease senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Elevated cortical zinc in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Rapid induction of Alzheimer A beta amyloid formation by zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid {beta} peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

New insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Protective effect of zinc on amyloid-beta 25-35 and 1-40 mediated toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

N-Terminal deletions modify the Cu2+ binding site in amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Methylation of the imidazole side chains of the Alzheimer disease amyloid-beta peptide results in abolition of superoxide dismutase-like structures and inhibition of neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Coordination abilities of the 1-16 and 1-28 fragments of beta-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Characterization of the ZnII binding to the peptide amyloid-beta1-16 linked to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and in vitro aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Zinc binding agonist effect on the recognition of the beta-amyloid (4-10) epitope by anti-beta-amyloid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

The galvanization of beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Application of a novel analysis to measure the binding of the membrane-translocating peptide penetratin to negatively charged liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

The metallobiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Abeta(1-28) fragment of the amyloid peptide predominantly adopts a polyproline II conformation in an acidic solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

A left-handed 3(1) helical conformation in the Alzheimer Abeta(12-28) peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Accurate measurement of translational diffusion coefficients: a practical method to account for nonlinear gradients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

The Alzheimer β-peptide shows temperature-dependent transitions between left-handed 31-helix, β-strand and random coil secondary structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

Translational diffusion measured by PFG-NMR on full length and fragments of the Alzheimer Aβ(1-40) peptide. Determination of hydrodynamic radii of random coil peptides of varying length

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2006.05563.X

10.1111/J.1742-4658.2006.05563.X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

17222176

1 reference

13 May 2018